Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,722.00p
   
  • Change Today:
      48.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 93,794
  • Market Cap: 1,790.26m
  • RiskGrade: 128
Select chart: 1 week | 1 month | 3 month | 6 month | 1 year
 

Current

1 year

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 573.35 71.79 83.74p 32.5 n/a -17% 32.38p 1.2%
30-Jun-23 617.36 80.64 93.77p 29.0 2.4 +12% 35.01p 1.3%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
30-Jun-2022 573 573 573 596 610 614
30-Jun-2023 617 617 617 644 n/a n/a
 
Earnings
30-Jun-2022 83.74p 83.74p 83.74p 91.47p 100.18p 108.47p
30-Jun-2023 93.77p 93.77p 93.77p 106.18p n/a n/a
 
Dividend
30-Jun-2022 32.38p 32.38p 32.38p 33.61p 34.04p 34.02p
30-Jun-2023 35.01p 35.01p 35.01p 36.70p n/a n/a
 
Recommendations
Strong Buy 4 4 4 4 2 4
Buy 0 0 0 0 1 1
Neutral 2 2 2 2 3 2
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 6 6 6 6 6 7
 
Average Rec 8.33 8.33 8.33 8.33 7.08 8.21

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,722.00p
Change Today 48.00p
% Change 1.80 %
52 Week High 6,070.00
52 Week Low 2,234.00
Volume 93,794
Shares Issued 65.77m
Market Cap 1,790.26m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.98% below the market average94.98% below the market average94.98% below the market average94.98% below the market average94.98% below the market average
92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average
Price Trend
80.7% below the market average80.7% below the market average80.7% below the market average80.7% below the market average80.7% below the market average
17.46% below the sector average17.46% below the sector average17.46% below the sector average17.46% below the sector average17.46% below the sector average
Income
83.88% below the market average83.88% below the market average83.88% below the market average83.88% below the market average83.88% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
54.94% above the market average54.94% above the market average54.94% above the market average54.94% above the market average54.94% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 2
Sell 0
Strong Sell 0
Total 6
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 26-May-2022

Time Volume / Share Price
17:13 41 @ 2,724.00p
16:35 20,535 @ 2,722.00p
16:29 2 @ 2,724.00p
16:29 75 @ 2,724.00p
16:29 64 @ 2,728.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page